Impact of Pharmacogenomics on Public Healthcare Policy

During the last fifteen years tremendous advances have been made in deciphering the genetic coding of a variety of species from invertebrates, vertebrates and finally man through the formal initiation of the Human Genome Project in October 2000 and its completion in 2003. This information has helped to increase our understanding of how genetics has a pivotal role in the predisposition of many diseased states, the progression of a course of a disease, as well as a patient’s response to a drug, or lack of it. Now in the 21st Century there is a growing trend towards the development of personalized medicine – the right drug for the right individual.

Examine the rapidly advancing fields of pharmacogenomics and pharmacogenetics, and measure the impact of pharmacogenomic techniques on reimbursement and health economics with this new report.